ストックスクリーナーアプリを入手
36.61
0.73%
-0.27
アフターアワーズ：
36.61
前日終値:
$36.88
開ける：
$36.76
24時間の取引高:
371.08K
Relative Volume:
0.69
時価総額：
$1.89B
収益：
$413.05M
当期純損益:
$-27.67M
株価収益率:
-65.26
EPS:
-0.561
ネットキャッシュフロー:
$-30.75M
1週間 パフォーマンス:
+4.45%
1か月 パフォーマンス:
+4.60%
6か月 パフォーマンス:
+8.70%
1年 パフォーマンス:
+11.18%
1日の値動き範囲:
$35.72
$36.93
1週間の範囲:
$34.77
$37.44
52週間の値動き範囲:
$27.55
$40.71
Immunocore Holdings Plc Adr Stock (IMCR) Company Profile
名前
Immunocore Holdings Plc Adr
セクター
電話
01235 5430281
住所
90 PARK DRIVE, OXFORDSHIRE
Compare IMCR vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMCR
Immunocore Holdings Plc Adr
|
36.61 | 1.87B | 413.05M | -27.67M | -30.75M | -0.561 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immunocore Holdings Plc Adr Stock (IMCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-16 | ダウングレード | Jefferies | Buy → Hold |
| 2026-01-07 | アップグレード | UBS | Sell → Buy |
| 2025-10-31 | 開始されました | Wells Fargo | Overweight |
| 2025-09-18 | 再開されました | Guggenheim | Neutral |
| 2025-08-25 | 再開されました | Jefferies | Buy |
| 2025-05-27 | 開始されました | Deutsche Bank | Buy |
| 2024-12-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-11-11 | ダウングレード | Mizuho | Outperform → Neutral |
| 2024-10-24 | 開始されました | UBS | Sell |
| 2024-10-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-04-29 | 開始されました | Leerink Partners | Outperform |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-11-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-31 | 開始されました | Robert W. Baird | Outperform |
| 2023-09-13 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-13 | 開始されました | Needham | Buy |
| 2023-08-16 | 開始されました | CapitalOne | Overweight |
| 2023-07-17 | 開始されました | Canaccord Genuity | Hold |
| 2023-03-31 | 開始されました | Mizuho | Buy |
| 2023-03-30 | 開始されました | Guggenheim | Buy |
| 2023-03-24 | 開始されました | Bryan Garnier | Buy |
| 2022-12-16 | アップグレード | Goldman | Neutral → Buy |
| 2022-11-30 | 開始されました | Barclays | Overweight |
| 2022-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-08 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-08-08 | 開始されました | Cowen | Outperform |
| 2022-08-02 | 開始されました | BTIG Research | Buy |
| 2022-02-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-20 | 開始されました | Oppenheimer | Outperform |
| 2021-03-02 | 開始されました | Goldman | Neutral |
| 2021-03-02 | 開始されました | JP Morgan | Overweight |
| 2021-03-02 | 開始されました | Jefferies | Buy |
すべてを表示
Immunocore Holdings Plc Adr (IMCR) 最新ニュース
Q3 Earnings Estimate for Immunocore Issued By HC Wainwright - MarketBeat
Q3 Earnings Forecast for Immunocore Issued By HC Wainwright - MarketBeat
IMCR Jumps 21.2% in 3 Months as Kimmtrak Growth Fuels More Momentum - Yahoo Finance
Is IMCR Worth Buying as Kimmtrak Growth Meets a Premium Valuation? - Yahoo Finance
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss - TradingView
Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues - TradingView
Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - Yahoo Finance Singapore
Immunocore Q2 2026 Earnings Call Transcript - MarketBeat
Immunocore Q2 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Immunocore posts Q2 2026 revenue beat as EPS misses - Investing.com
Immunocore Holdings earnings missed by $0.03, revenue topped estimates - Investing.com
Immunocore set to report earnings ahead of pivotal trial data - Investing.com
Immunocore Holdings PLC Sponsored ADR $IMCR Position Boosted by Janus Henderson Group PLC - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Stempoint Capital LP Purchases New Shares in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Eversept Partners LP Takes Position in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
How Immunocore Is Expanding Beyond Its Rare-Cancer Drug Kimmtrak - Yahoo! Finance Canada
Is Immunocore Stock Attractive After Kimmtrak's Strong Sales Growth? - TradingView
Immunocore's Kimmtrak Growth Story and Major 2026 Catalysts Ahead - TradingView
Principal Financial Group Inc. Sells 139,306 Shares of Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
EU Approves Expanded Use of ABBV's Tepkinly in Follicular Lymphoma - TradingView
PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare - TradingView
Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why - TradingView
IMCR News | IMMUNOCORE HOLDINGS PLC-ADR (NASDAQ:IMCR) - ChartMill
Is it a good idea to invest in Immunocore stock right now? - MSN
Here's Why You Should Add Kiniksa Stock to Your Portfolio Now - TradingView
Here's Why You Should Add ANIX Stock to Your Portfolio Now - TradingView
Reasons Why Investors Should Consider Betting on Indivior Stock - TradingView
RVMD Starts Treatment in Phase III Pancreatic Cancer Study on Zoldonrasib - TradingView
NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push - TradingView
BEAM Stock Gains 5% as FDA Clears BEAM-304 IND for Phenylketonuria - TradingView
PFE Stock Slides Following CFO Exit, 2026 Guidance Reaffirmed - TradingView
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies - TradingView
DNTH Shares Surge 89% Over the Past Six Months: What's Driving It? - TradingView
Is it a Good Idea to Invest in Immunocore Stock Right Now? - TradingView
MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised) - TradingView
NTLA Posts Strong Additional Phase III Data From HAE Study, Stock Up - TradingView
Neumora Stock Plunges 49% After Late-Stage Depression Drug Failure - TradingView
MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review - TradingView
INDV Stock: What Sublocade Growth Signals for 2026 - TradingView
GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder - TradingView
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why - TradingView
HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US - TradingView
Sanofi Ends Late-Stage Study on Neurology Drug Over Weak Results - TradingView
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs - TradingView
RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week? - TradingView
Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know - TradingView
ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data - TradingView
Amgen Secures EU Nod for Imdylltra in Lung Cancer Indication - TradingView
MRNA Partners With CEPI to Develop Vaccine for Bundibugyo Ebolavirus - TradingView
REPL Stock Soars on Plans of BLA Resubmission for Melanoma Combo Drug - TradingView
Immunocore Holdings Plc Adr (IMCR) 財務データ
収益
当期純利益
現金流量
EPS
0.00%
3.22%
大文字化:
|
ボリューム (24 時間):